How to evaluate the immune status of lung cancer patients before immunotherapy
Nowadays, cancer immunotherapy is a promising strategy in solid tumour treatment. It has become a breakthrough in achieving long-term survival in many advanced cases. The essence of modern immunotherapy is to improve the host antitumour immune defence. Currently, it is critically important to determ...
Main Authors: | Joanna Domagala-Kulawik, Agata Raniszewska |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2017-12-01
|
Series: | Breathe |
Online Access: | http://breathe.ersjournals.com/content/13/4/291.full |
Similar Items
-
Lung cancer stem cells – the role in pathogenesis and progressive growth of cancer
by: Agata Raniszewska, et al.
Published: (2017-12-01) -
Immunophenotype of T Cells Expressing Programmed Death-1 and Cytotoxic T Cell Antigen-4 in Early Lung Cancer: Local vs. Systemic Immune Response
by: Iwona Kwiecien, et al.
Published: (2019-04-01) -
Lung Cancer Stem Cells—Origin, Diagnostic Techniques and Perspective for Therapies
by: Agata Raniszewska, et al.
Published: (2021-06-01) -
Immunomodulatory Molecules On Lung Cancer Stem Cells From Lymph Nodes Aspirates
by: Agata Raniszewska, et al.
Published: (2020-03-01) -
Blood Monocyte Subsets with Activation Markers in Relation with Macrophages in Non-Small Cell Lung Cancer
by: Iwona Kwiecień, et al.
Published: (2020-09-01)